Large gap with delayed quotes
|
Last quote
07/17/2026
-
17:31:48
|
Bid
07/17/2026 -
18:16:29
|
Bid Volume |
Ask
07/17/2026 -
17:40:00
|
Ask Volume |
|---|---|---|---|---|
|
49.55
-0.05
(
-0.10% )
|
48.60
|
60 |
50.20
|
52 |
Analysis date: 14.07.2026
Global Evaluation
Slightly positive
Slightly positive
The stock is classified in the slightly positive zone since 19.06.2026.
Interest
Strong
Strong
Three stars since 23.06.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 01.05.2026 at a price of 44.15.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 19.06.2026.
4wk Rel Perf
13.77%
13.77%
The four-week dividend-adjusted overperformance versus STOXX600 is 13.77%.
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 24.02.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.67%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.15%.
Mkt Cap in $bn
3.39
3.39
With a market capitalization between $2 & $8bn, BB BIOTECH AG is considered a mid-cap stock.
G/PE Ratio
-3.44
-3.44
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
16.51
16.51
The estimated PE is for the year 2026.
LT Growth
-62.84%
-62.84%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
6.01%
6.01%
The twelve month estimated dividend yield represents 99.17% of earnings forecasts.
Beta
70
70
For 1% of index variation, the stock varies on average by 0.70%.
Correlation
0.33
0.33
Stock movements are strongly independent of index variations.
Value at Risk
5.69
5.69
The value at risk is estimated at CHF 5.69. The risk is therefore 11.35%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
22.07.2014
22.07.2014